Patents Assigned to Excelmab, Inc.
  • Bispecific antibody and uses thereof
    Patent number: 11718671
    Abstract: Provided is a novel antibody and a method for treating breast cancer. More specifically, the present disclosure relates to a bispecific antibody targeting CD3 and a tumor antigen target such as HER2, a preparation method, and uses thereof. The present disclosure also relates to a composition containing said antibody and a method for treating cancer by using the antibody.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: August 8, 2023
    Assignee: Excelmab, Inc.
    Inventors: Wenjun Zhang, Cuijuan Chen, Xuemei Wei, Tonghui Luo